Showing 1 - 7 results of 7 for search 'Tanya A. Camacho-Villegas', query time: 0.04s Refine Results
  1. 1
    vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target

    vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target by Alejandro Manzanares-Guzmán, Pavel H. Lugo-Fabres, Tanya A. Camacho-Villegas

    Published 2024-03-01
    Get full text
    Article
  2. 2
    3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery

    3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery by Guadalupe Tonantzin de Dios-Figueroa, Janette del Rocío Aguilera-Marquez, Tanya A. Camacho-Villegas, Pavel H. Lugo-Fabres

    Published 2021-05-01
    Get full text
    Article
  3. 3
    First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment

    First pan-specific vNAR against human TGF-β as a potential therapeutic application: in silico modeling assessment by Mirna Burciaga-Flores, Ana Laura Márquez-Aguirre, Salvador Dueñas, Jahaziel Gasperin-Bulbarela, Alexei F. Licea-Navarro, Tanya A. Camacho-Villegas

    Published 2023-03-01
    Get full text
    Article
  4. 4
    Embedded Living HER2+ Cells in a 3D Gelatin–Alginate Hydrogel as an In Vitro Model for Immunotherapy Delivery for Breast Cancer

    Embedded Living HER2+ Cells in a 3D Gelatin–Alginate Hydrogel as an In Vitro Model for Immunotherapy Delivery for Breast Cancer by G. Tonantzin De Dios-Figueroa, Janette del Rocío Aguilera-Márquez, Lorena García-Uriostegui, Rodolfo Hernández-Gutiérrez, Tanya A. Camacho-Villegas, Pavel H. Lugo-Fabres

    Published 2023-09-01
    Get full text
    Article
  5. 5
    Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization

    Intraocular Penetration of a vNAR: In Vivo and In Vitro VEGF165 Neutralization by Tanya A. Camacho-Villegas, María Teresa Mata-González, Walter García-Ubbelohd, Linda Núñez-García, Carolina Elosua, Jorge F. Paniagua-Solis, Alexei F. Licea-Navarro

    Published 2018-03-01
    Get full text
    Article
  6. 6
    In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2

    In Vitro Antiviral Activity of Nordihydroguaiaretic Acid against SARS-CoV-2 by Erendira Villalobos-Sánchez, Daniel García-Ruiz, Tanya A. Camacho-Villegas, Alejandro A. Canales-Aguirre, Abel Gutiérrez-Ortega, José E. Muñoz-Medina, Darwin E. Elizondo-Quiroga

    Published 2023-05-01
    Get full text
    Article
  7. 7
    Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from <i>Californiconus californicus</i>, for Treating Type 2 Diabetes

    Potential Therapeutic Applications of Synthetic Conotoxin s-cal14.2b, Derived from <i>Californiconus californicus</i>, for Treating Type 2 Diabetes by Pavel H. Lugo-Fabres, Leslie M. Otero-Sastre, Johanna Bernáldez-Sarabia, Tanya A. Camacho-Villegas, Noemi Sánchez-Campos, Janeth Serrano-Bello, Luis A. Medina, Saé Muñiz-Hernández, Lizbeth de la Cruz, Isabel Arenas, Antonio Barajas-Martínez, David E. Garcia, Linda Nuñez-Garcia, Jorge González-Canudas, Alexei F. Licea-Navarro

    Published 2021-08-01
    Get full text
    Article

Search Tools: